Montelukast Intermediate is a leukotriene receptor antagonist (LTRA)
Montelukast Intermediate used to prevent wheezing, difficulty in breathing, chest tightness, and coughing caused by asthma.

The global Montelukast Intermediate market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Montelukast Intermediate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Montelukast Intermediate market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
VIVAN Life Sciences
P.G. Shah & Co.
Manus Aktteva Biopharma
Ortin Laboratories
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
GMP
Non-GMP

Segment by Application
Asthma
Allergic Rhinitis
Bronchospasm
Urticaria